Lee Glavin
Fabio vel iudice vincam, sunt in culpa qui officia. Morbi odio eros, volutpat ut pharetra vitae, lobortis sed nibh. Quid securi etiam tamquam eu fugiat nulla pariatur.
Fabio vel iudice vincam, sunt in culpa qui officia. Morbi odio eros, volutpat ut pharetra vitae, lobortis sed nibh. Quid securi etiam tamquam eu fugiat nulla pariatur.
Annual Meeting 2022: Opening Plenary Showcases Cutting-edge Scientific Program
Learn More“No Time to Stop the Momentum”
Learn MoreNCI-MATCH Trial Opens
Learn MoreFDA Approval Rounded Out a Successful 2014 for Cancer Immunotherapy
Learn MoreStructural Racism and Cancer Disparities: Looking at All the Angles
Learn MoreThree AACR Reports Capture the State of Cancer Science and Medicine in 2022
Learn MoreWhat’s New in Immune Cell Therapy Research?
Learn MoreTaking a BiTE Out of Cancer
Learn MoreDisrupting a Link Between Obesity and Cancer
Learn MoreAACR Virtual Annual Meeting I: A Roundup of Cancer Research Catalyst Posts
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: